KLF4 Inhibits the Activation of Human Hepatic Stellate Cell In Vitro
Current Medical Science · 2024
DOI: 10.1007/s11596-024-2860-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Medical Science, 2024. Verfasst von Xing-Yu Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Kruppel-Like Factor 4, Kruppel-Like Transcription Factors, Cell Proliferation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Hepatic stellate cells (HSCs) play a crucial role in liver fibrosis. Early-stage liver fibrosis is reversible and intimately associated with the state of HSCs. Kruppel-like factor 4 (KLF4) plays a pivotal role in a wide array of physiological and pathological processes. This study aimed to investigate the effect of KLF4 on the proliferation, apoptosis and phenotype of quiescent HSCs METHODS: We designed a KLF4 lentiviral vector and a KLF4 siRNA lentiviral vector, to upregulate and silence KLF4 expression in human HSC LX-2 cells via transfection. Cell proliferation was assessed using the CCK-8 assay. Flow cytometry was used to detect the cell cycle distribution and apoptosis rate. Western blotting was used to determine the levels of some quiescence and activation markers of HSCs RESULTS: Overexpression of KLF4 significantly increased the levels of E-cadherin and ZO-1, which are quiescent HSC markers, while significantly decreased the levels of N-cadherin and a-SMA, known activated HSC markers. In contrast, cell proliferation and apoptosis rates were elevated in LX-2 cells in which KLF4 expression was silenced CONCLUSION: KLF4 inhibits the proliferation and activation of human LX-2 HSCs. It might be a key regulatory protein in the maintenance of HSC quiescence and may serve as a target for the inhibition of hepatic fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
- Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
- Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. xueyinkai@126.com.
- Department of Emergency Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. zhenghai_xiehe@126.com.
Zitieren
APA
Yang, X. Y., Chen, Z., Tan, J., Xue, Y. K., & Zheng, H. (2024). KLF4 Inhibits the Activation of Human Hepatic Stellate Cell In Vitro. Current Medical Science. https://doi.org/10.1007/s11596-024-2860-8
Vancouver
Yang XY, Chen Z, Tan J, Xue YK, Zheng H. KLF4 Inhibits the Activation of Human Hepatic Stellate Cell In Vitro. Current Medical Science. 2024. doi:10.1007/s11596-024-2860-8
BibTeX
@article{Yang2024,
author = {Yang, Xing-Yu and Chen, Zhe and Tan, Jun and Xue, Yin-Kai and Zheng, Hai},
title = {KLF4 Inhibits the Activation of Human Hepatic Stellate Cell In Vitro},
journal = {Current Medical Science},
year = {2024},
doi = {10.1007/s11596-024-2860-8}
}
EUVIMED